Connection
Co-Authors
This is a "connection" page, showing publications co-authored by David Camidge and Roselinde Kaiser.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.108 |
|
|
|
-
Doebele RC, Conkling P, Traynor AM, Otterson GA, Zhao Y, Wind S, Stopfer P, Kaiser R, Camidge DR. A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol. 2012 Aug; 23(8):2094-2102.
Score: 0.108